Skip to main content

Table 9 Adjusted Relative Risk of VTE due to Cisplatin based Chemotherapy

From: Incidence of Venous Thromboembolism in cancer patients treated with Cisplatin based chemotherapy — a cohort study

  β coefficient SE (β) Relative Risk 95% CI for RR
Cisplatin based chemotherapy 1.2 0.37 3.32 1.6–6.8
  1. adjusted for ECOG, Khorana risk score, GCSF, presence of CVC and gender-log likelihood =471.38